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Campylobacter jejuni causes foodborne disease associated with abdominal pain, gastroenteritis, and
diarrhea. These symptoms are induced by bacterial adherence and invasion of host epithelial cells.
C. jejuni infection can occur with a low infective dose, suggesting that C. jejuni may have evolved stra-
tegies to cope with the bacterial clearance system in the gastrointestinal tract. The mucosa layer is the
ﬁrst line of defense against bacteria. Mucus conditions are maintained by water and anion (especially
Cl) movement. Cystic ﬁbrosis transmembrane conductance regulator (CFTR) is the main Cl channel
transporting Cl to the lumen. Mutations in CFTR result in dehydrated secreted mucus and bacterial
accumulation in the lungs, and recent studies suggest that closely related pathogenic bacteria also may
survive in the intestine. However, the relationship between C. jejuni infection and CFTR has been little
studied.
Here, we used an 125I efﬂux assay and measurement of short-circuit current to measure Cl secretion
in C. jejuni-infected T-84 human intestinal epithelial cells. The basic state of Cl secretion was unchanged
by C. jejuni infection, but CFTR activator was observed to induce Cl secretion suppressed in C. jejuni-
infected T-84 cells. The suppression of activated Cl secretion was bacterial dose-dependent and
duration-dependent. A similar result was observed during infection with other C. jejuni strains.
The mechanism of suppression may occur by affecting water movement or mucus condition in the
intestinal tract. A failure of mucus barrier function may promote bacterial adhesion or invasion of host
intestinal epithelial cells, thereby causing bacterial preservation in the host intestinal tract.
© 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
Published by Elsevier Ltd. All rights reserved.his journal by chairperson at the conference of the 87th Annual Conference of The Japanese Association for Infectious
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Campylobacter jejuni is a commensal bacterium in birds and
domestic animals that frequently causes gastrointestinal food-
borne disease in humans. Infection with C. jejuni is a major cause
of human bacterial gastroenteritis responsible for more than 400
million cases worldwide each year [1]. C. jejuni infection causes
digestive symptoms such as abdominal pain, intestinal inﬂam-
mation, and diarrhea. C. jejuni pathogenicity is driven by the
production of pro-inﬂammatory cytokines such as IL-8 in intestinal
epithelial cells. Previous studies showed that C. jejuni adherence
and invasion correlate with activation of MAP kinases leading to
production of the pro-inﬂammatory cytokine, IL-8 [2]. Thus, bac-
terial internalization into intestinal epithelial cells is important for
understanding digestive symptoms induced by C. jejuni infection.
Interestingly, C. jejuni infection can occur with very low infective
doses (500e800 bacteria) and long incubation periods (2e7 days)
[3]. Those reports suggest that C. jejuni may have evolved strate-
gies to cope with the bacterial clearance system. Bacterial inter-
nalization into epithelial cells followed by colonization and
accumulation may be one such strategy for survival in the
gastrointestinal tract.
The mucus condition is a critical determinant of bacterial
infection. The mucosa layer of the intestinal tract is the ﬁrst line of
defense against bacteria. It is continuously secreted and is
composed of high molecular mass oligomeric mucin glycopro-
teins. Mucus acts to prevent bacterial attachment and entry into
intestinal epithelial cells. A previous study reported that mucin
mutant mice have a higher rate of C. jejuni colonization [4]. Water
ﬂux plays an important role in the maintenance of the mucus
barrier function in the intestinal tract. Dehydration of mucus at-
tenuates the mucosa layer movement necessary to clear trapped
material.
Anion secretion is closely associated with hydration of the
intestinal mucus and clearance of intestinal contents, so that in-
testinal water balance is regulated by transepithelial ionic
movement [5]. Cl accounts for 65e70% of all anions in mammals
and plays a key role in body ﬂuid homeostasis. Cystic ﬁbrosis
transmembrane conductance regulator (CFTR) is the main Cl
channel expressed in apical membranes of intestinal epithelial
cells, and transports Cl to the lumen via cAMP or cGMP path-
ways [6]. Cystic ﬁbrosis (CF) is known to be caused by the loss or
dysfunction of CFTR activity resulting from CFTR mutations,
leading to aberrant ion and ﬂuid homeostasis in several tissues
and organs, including the lung and gastrointestinal tract [7]. The
interaction between CFTR and bacterial infection is well under-
stood in the airway. CF patients have dehydrated mucus and
attenuated water movement caused by decreased Cl secretion
leading to stasis, resulting in chronic bacterial infections in lung
[8]. CFTR is also highly expressed in the intestinal tract, and CFTR
mutations might be associated with intestinal infections. Indeed,
a previous study showed that enteropathogenic Escherichia coli
and Salmonella enteritidis suppress Cl transport activity in the
intestinal tract [9,10]. These reports suggest that Cl secretion
mediated by CFTR could be critical for bacterial clearance in the
intestine, and that CFTR may play a key role in the intestinal host
defense mechanism.
The purpose of this study was to examine the inﬂuence of
C. jejuni infection on CFTR activity. We examined Cl secretion
mediated by CFTR by 125I efﬂux assay and measurement of short-
circuit current in C. jejuni-infected T-84 cells. Our data showed that
forskolin-induced CFTR activation was suppressed by C. jejuni
infection in T-84 cells. This study may help to elucidate C. jejuni
survival mechanisms in the intestinal tract.Please cite this article in press as: Negoro S, et al., Campylobacter jejuni
84 cells, J Infect Chemother (2014), http://dx.doi.org/10.1016/j.jiac.2014.02. Materials and methods
2.1. Bacterial strains and culture conditions
C. jejuni strains NCTC11168 (ATCC 700819) [11] and 81-176
(ATCC BAA2151) [12] were obtained from American Type Culture
Collection (ATCC). NCTC11168 strain was used as a standard strain
in this study. The bacteria were cultured in Muller Hinton Broth
(DIFCO) under microaerobic conditions (5% O2, 10% CO2, 85% N2) at
37 C for 48 h. The bacteria cells were diluted into fresh MH and
grown under microaerobic conditions at 37 C for 36 h.
2.2. Cell culture
T-84 cells, the human intestinal epithelial cells, were cultured
in Dulbecco's modiﬁed eagle's medium nutrient mixture F-12
HAM (DMEM/F-12, 1:1; SigmaeAldrich) supplemented with 10%
fetal bovine serum (FBS; Hyclone), and 100 mg/ml gentamicin
(SigmaeAldrich). The cells were seeded on 6-well culture dishes
at a density of 3  106 cells/well, and cultured for 7 days. The cells
were incubated at 37 C in a humidiﬁed atmosphere containing
5% CO2. A 2 ml aliquot of cell culture medium was changed every
2 days.
2.3. Infection protocol
The culture medium for T-84 cells was replaced with fresh
DMEM/F-12 medium (without supplements) before infection.
Bacteria were centrifuged and resuspended in phosphate buffered
saline (PBS) (pH 7.4) and adjusted for concentration with PBS. The
bacterial suspensions were added to each well, and the T-84 cells
were infected with multiplicity of infection (MOI) of 20 for 12 h.
Infections were carried out at 37 C in 5% CO2.
2.4. Reagents
Forskolin and CFTRinhibitor172 were obtained from Calbiochem.
CPT-cAMP, prostaglandin E2 (PGE2), and ATP were obtained from
SigmaeAldrich. The stock of forskolin, CFTRinhibitor172 and CPT-
cAMP were dissolved in DMSO. The stock of PGE2 and ATP were
dissolved in water.
2.5. Efﬂux assay
The utilization of cellular 125I efﬂux to study Cl secretion has
been reported previously [13,14]. After infection as described
above, the T-84 cells were loaded with radioactive 125I by incu-
bating for 1 h at 37 C with 1 ml HEPES buffer (10 mM HEPES,
145 mM NaCl, 10 mM glucose, 5 mM KCl, 1 mMMgCl2, 1 mM CaCl2)
containinge2 mCi/ml Na125I (Perkin Elmer). T-84 cells were washed
three times with 1 ml isotope-free HEPES buffer and 1 ml of HEPES
buffer was added into each well. The supernatant samples were
removed at 2 min intervals and replaced with fresh HEPES buffer.
This process was repeated 4e5 times with or without Cl secretion
agonist (forskolin, CPT-cAMP, PGE2, and ATP). After the last super-
natant sample collection, the T-84 cells were lysed with 1 ml 0.1 M
NaOH for 1 h at 37 C and recovered. Amounts of 125I in recovered
supernatant and cell lysis sampleweremeasured using a g-counter.
Total counts were calculated from the sum of counts from cell lysis
sample and from all the supernatant samples. Efﬂux is indicated as
the percent of the total count remaining at the end of each efﬂux
period. The percentage efﬂux was calculated as below: %
efﬂux ¼ (count secreted)/(total count remaining in the cells each
minute)  100.infection suppressed Cl secretion induced by CFTR activation in T-
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Fig. 1. 125I efﬂux and intercellular cAMP products are unchanged by C. jejuni infection
in T-84 cells. T-84 cells were infected with C. jejuni (NCTC11168) for 12 h. Cl secretion
was measured using an 125I efﬂux assay. The cells were pre-loaded with 125I and
6 min efﬂux was saved for counting (a). Forskolin was used as a positive control in the
efﬂux assay, and CFTR-mediated Cl secretion was conﬁrmed by CFTRinhibitor172.
Intracellular cAMP production was measured by an enzyme-linked immunosorbent
assay (b).T-84 cells were infected with C. jejuni, and cells were treated with 10 mM
forskolin for 5 min as positive controls. Results are shown as the mean ± SD calculated
from the results of 3 independent experiments. n.s. not statistically signiﬁcant.
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T-84 cells were cultured on 24-well plates and infected with
C. jejuni at an MOI of 20 for 12 h. After infection, T-84 cells were
stimulated with 10 mM forskolin or vehicle for 5 min. Intracellular
cAMP contents in T-84 cells were measured by an enzyme immu-
noassay (EIA) system product kit (GE Healthcare Bio-Sciences) as
per the manufacturer's instructions.
2.7. Measurement of ion transport
Measurement of short-circuit current to study ion transport has
been previously reported [15]. T-84 cells were grown on the
transwell for 7 days in order to obtain an electrical resistance
greater than 800 U/cm2. After infection as described above, the T-
84 cells were washed with KrebseRinger solution (117 mM NaCl,
4.7 mM KCl, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 25 mM NaHCO3,
2.5 mM CaCl2, 11 mM glucose) and were bathed in KrebseRinger
solution bubbled with 95% O2 and 5% CO2 for 10 min. T-84 cells
were mounted in a modiﬁed hand-made Ussing chamber for
measurement of ion transport. Continuous application of a short-
circuit current (Isc) was maintained by a short-circuit current
ampliﬁer (NIHON KOHDEN CEZ-9100). Isc was recorded by a poly-
graph (San-ei, Omni light 8M36). Secretion was stimulated by
10 mM forskolin on the basolateral side for 10 min. CFTRinhibitor172
(15 mM) was added to the apical side after stimulation with for-
skolin. Isc (DIsc) mediated by CFTR was calculated by the difference
between CFTRinhibitor172 treated current (minimum current) and
forskolin-stimulated current (maximum current).
2.8. Cytotoxicity assay
T-84 cells were seeded on 24-well plate and infected with
C. jejuni at an MOI of 20 for 12 h. After infection, supernatants were
collected on a new plate, and extracellular lactate dehydrogenase
(LDH) was measured using a Cytotoxicity Detection Kit (Promega)
following the manufacturer's directions.
3. Results
Infection with C. jejuni did not activate CFTR Cl secretion or
cAMP production in T-84 cells.
C. jejuni infection is known to cause diarrhea. Previous reports
showed that E. coli or Vibrio cholerae infection activates Cl secre-
tion mediated by CFTR via cAMP or cGMP, causing diarrhea. Chol-
erae toxin (CT) and heat-labile enterotoxin (LT), homologous to CT,
produced by V. cholerae increase cAMP and activate CFTR. Heat-
stable enterotoxin (ST), another major enterotoxin product from
E. coli, increases cGMP and activates CFTR [16,17]. These reports led
us to hypothesize that C. jejuni infection might also activate Cl
secretion mediated by CFTR. To investigate whether C. jejuni
infection would activate Cl secretion mediated by CFTR, we
investigated Cl secretion in C. jejuni-infected cells. In this study,
Cl secretion was measured by 125I efﬂux from T-84 cells, human
intestinal epithelial cells. Cl secretion in T-84 cells was not acti-
vated by C. jejuni infection (Fig. 1(a)). Furthermore, production of
CFTR activating secondmessenger, cAMP (Fig. 1(b)) and cGMP (data
not shown) was not signiﬁcantly different between infected cells
and no-infected cells. Our data suggested that the mechanism of
causing diarrhea induced by C. jejuni infection was different from
bacterial toxin-induced diarrhea caused by E. coli or V. cholerae.
Infection with C. jejuni suppressed forskolin-activated Cl
secretion mediated by CFTR in T-84 cells.
Inﬂammatory mediators such as prostaglandin E2 (PGE2) pro-
mote cAMP production and activate CFTR [18,19]. During C. jejuniPlease cite this article in press as: Negoro S, et al., Campylobacter jejuni
84 cells, J Infect Chemother (2014), http://dx.doi.org/10.1016/j.jiac.2014.0infection, the inﬂammatory mediator IL-8 is secreted from intesti-
nal epithelium cells, and production of the cytokine induces
inﬂammation in the intestinal tract [2]. To investigate any inter-
action between C. jejuni infection and CFTR with regards to
inﬂammation, we evaluated ion transport under forskolin, cAMP
agonist, stimulated conditions as an inﬂammatory model by mea-
surement of ion transport with an Ussing chamber. We found that
C. jejuni infection suppressed CFTR-dependent ion transport
(Fig. 2(aec)). During the infection period, C. jejuni infection did not
cause release of the cytosolic enzyme lactate dehydrogenase (LDH),
a marker of cytotoxicity, from T-84 cells (Fig. 2(d)). These data
suggested that suppression of ion transport by C. jejuni infections
was not related to cell death. Suppression of forskolin-activated Cl
secretion by C. jejuni infection was also observed by the 125I efﬂux
assay (Fig. 3(a)). The results of efﬂux assay agreed with measure-
ments of ion transport. Furthermore, to conﬁrm that the suppres-
sion of Cl secretion was directly induced by C. jejuni infection, we
checked forskolin-activated Cl secretion in several infective con-
ditions. C. jejuni infection caused bacterial dose-dependent and
duration-dependent reduction of CFTR-mediated Cl secretion
(Fig. 3(b and c)). Suppression of forskolin-activated Cl secretioninfection suppressed Cl secretion induced by CFTR activation in T-
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Fig. 2. C. jejuni infection suppressed CFTR-mediated ion secretion in forskolin-stimulated T-84 cells. T-84 cell monolayers were grown on transwells, and mounted on an Ussing
chamber for measuring ion transport. Short-circuit current (Isc) was measured through stimulation with 10 mM forskolin followed by 13 mM CFTRinhibiror172 in no-infected T-
84 cells (a) and C. jejuni-infected T-84 cells (b), and the data were quantiﬁed (c). C. jejuni infection dependent cell cytotoxicity (d) was assayed by measuring cellular LDH release into
the culture medium (d). T-84 cells were infected with C. jejuni (black bar) or left uninfected (white bar) for the indicated times, and LDH was measured in the medium. Results are
shown as the mean ± SD calculated from the results of 3 (c) or 4 (d) independent experiments. *p & 0.05; **p & 0.01; n.s. not statistically signiﬁcant.
S. Negoro et al. / J Infect Chemother xxx (2014) 1e74was observed not only with the C. jejuni NCTC11168 strain, the
standard strain in this study, but also with the 81-176 strain
(Fig. 3(d)). Our data indicated that C. jejuni infection suppressed
forskolin-activated Cl secretion regardless of the C. jejuni strain.
These data strengthen the hypothesis that CFTR-mediated Cl
secretion is silenced during C. jejuni infection in the human intes-
tinal tract.
The stimulus of CFTR activator-dependent Cl secretion was
suppressed by C. jejuni infection in T-84 cells.
In order to conﬁrmwhether the reduction of CFTR-mediated Cl
secretion was forskolin stimulation dependent, we evaluated Cl
secretion stimulated by other CFTR activators in C. jejuni-infected T-
84 cells. CPT-cAMP is a membrane-permeable activator of CFTR.
Under CPT-cAMP stimulus, Cl secretionwas suppressed by C. jejuni
infection (Fig. 4(a)). As mentioned above, C. jejuni infection would
induce inﬂammation in the intestinal tract. PGE2, an inﬂammatory
mediator, increases intracellular cAMP and activates CFTR [18,19].
Under PGE2 stimulus, C. jejuni infection suppressed PGE2-induced
Cl secretion (Fig. 4(b)). Our data indicated that C. jejuni infection
induces the suppression of Cl secretion activated by all stimulators
of CFTR activation used in this study.
Finally, we investigated whether the suppression of Cl secre-
tion by C. jejuni infection was relevant for another Cl channel. We
investigated the inﬂuence of C. jejuni infection on the Ca2þ-Please cite this article in press as: Negoro S, et al., Campylobacter jejuni
84 cells, J Infect Chemother (2014), http://dx.doi.org/10.1016/j.jiac.2014.0activated chloride channel (CaCC). CaCC also plays an important
role in Cl secretion in the intestinal tract like CFTR, and is activated
by ATP via G protein coupled receptor (GPCR) pathways [20,21]. We
investigated ATP-stimulated Cl secretion in T-84 cells infected
with C. jejuni. We observed that C. jejuni infection suppressed Cl
secretion activated by ATP (Fig. 4(c)). Our data showed that CaCC
was suppressed by C. jejuni infection, coincident with the attenu-
ation of CFTR in T-84 cells. These results raise the possibility that
C. jejunimay regulate Cl secretion and attenuate water movement
in the intestinal tract. We suspect that repression of water move-
ment leads to bacterial accumulation and survival in the intestinal
tract.
4. Discussion
CFTR is a key Cl channel in the intestinal tract, owing to its
close association with water movement in the intestinal epithe-
lium. CFTR is the critical downstream target of cAMP and cGMP-
mediated Cl secretion in the intestinal tract [6]. Some studies
have suggested that water movement induced by CFTR activity may
be associated with bacterial survival, and that mucus viscosity
defends against microbes and physical injury [8,22].
C. jejuni is major prevalent cause of foodborne diarrheal disease
worldwide [23]. Clinical strains of C. jejuni cause a variety ofinfection suppressed Cl secretion induced by CFTR activation in T-
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Fig. 3. Forskolin-induced 125I efﬂux was decreased by C. jejuni infection. T-84 cells were infected with C. jejuni for 12 h and were pre-loaded with 125I. The 125I efﬂux in T-84
infected with C. jejuniwas measured at 2 min intervals for a 10 min period. 10 mM forskolin was added 0 min after starting the efﬂux measurements. The 125I efﬂux in T-84 infected
with C. jejuni strain NCTC11168 (a) or 81-176 (d) was measured at 2 min intervals for a 10 min period. Relation between C. jejuni infection and suppression of Cl secretion was
validated by comparison of bacterial cell number and infection period. T-84 cells were infected with C. jejuni at indicated MOI (b) or for the indicated times (c) and were pre-loaded
with 125I. 10 mM forskolin was added 0 min after starting the efﬂux measurements. The 125I efﬂux in T-84 C. jejuni-infected cells was counted in 6 min efﬂux. The data were
normalized to the forskolin-unstimulated samples. Results were shown as the mean ± SD calculated from the results of 3 independent experiments. *p & 0.05; **p & 0.01.
S. Negoro et al. / J Infect Chemother xxx (2014) 1e7 5symptoms ranging from severe inﬂammatory bloody diarrhea to
no-inﬂammatory watery diarrhea [24]. We predicted that water
movement in the intestinal epithelium cells is associated with
C. jejuni survival during C. jejuni infection. In this study, we inves-
tigated the relationship between CFTR and C. jejuni infection. First,
we investigated Cl secretion in steady-state C. jejuni-infected T-
84 cells, but Cl secretion was not changed (Fig. 1(a)). Toxins
elaborated by V. cholerae or E. coli are known to activate CFTR and
secrete Cl via cAMP or cGMP in intestinal epithelial cells, leading
to diarrhea [16,17]. Our data suggested that the mechanism of
diarrhea induced by C. jejuni infection is different from the secre-
tory diarrhea induced by V. cholerae infection or E. coli infection.
Next, we investigated the effect of C. jejuni infection on activated
CFTR in T-84 cells. Production of intracellular cAMP, a CFTR acti-
vator, was increased by PGE2 in inﬂammation [18,19]. C. jejuni
infection induces IL-8 secretion and induces inﬂammation in in-
testinal cells [2]. Therefore, to examine Cl secretion during
inﬂammation, forskolin was used as an inﬂammation model. T-
84 cells were stimulated by forskolin after C. jejuni infection. We
observed that forskolin-stimulated CFTR activity was suppressed in
C. jejuni-infected T-84 cells (Fig. 2(aec)). The release of LDH, widely
known as a marker of cytotoxicity [25], was measured to evaluate
cell death. During the 0e12 h infection period, the release of LDH
was not changed (Fig. 2(d)). These data suggested that suppression
of Cl secretion by C. jejuni infectionwas not relatedwith cell death.
Furthermore, reduction of Cl secretion was observed in thePlease cite this article in press as: Negoro S, et al., Campylobacter jejuni
84 cells, J Infect Chemother (2014), http://dx.doi.org/10.1016/j.jiac.2014.0presence of other stimulators of CFTR activation (CPT-cAMP, and
PGE2) (Fig. 4(a and b)). Reduction of CFTR-mediated Cl secretion
was C. jejuni dose-dependent and duration-dependent (Fig. 3(b and
c)). Also, the diminished responsiveness to forskolin was found not
only in C. jejuni strain NCTC11168, the standard strain in this study,
but also in the 81-176 strain (Fig. 3(aed)). Finally, in order to
determine the effect of C. jejuni infection on another Cl channel,
we investigated the inﬂuence of C. jejuni infection on CaCC. CaCC is
known as a Cl channel that secretes Cl to the lumen and has an
important role in the maintenance of ion balance in the intestinal
tract [20,21].We observed that ATP-activated Cl secretionwas also
suppressed by C. jejuni infection. These data suggest that C. jejuni
infection suppresses Cl secretion, thereby attenuating water ﬂux
in intestinal epithelial cells.
Mucus is the ﬁrst barrier for pathogens entering the gastroin-
testinal tract. Enteric pathogens have to colonize and avoid the
mucosa layer prior to causing disease. To establish infection, these
bacteria have to circumvent mucus barriers in the gastrointestinal
tract. Mucus is particularly important for invasive bacteria, such as
C. jejuni. The mucosa layer is composed of high molecular mass
oligomeric mucin glycoproteins which confer mucus with its water
holding capacity [26]. In the epithelial cell surface, including the
mucosa layer, liquid balance is modulated by CFTR Cl secretion
which controls the concentration of mucosa layer contents. CFTR
inﬂuence on mucus is well-studied for respiratory disease in CF.
The absence of CFTR function dehydrates the airway surface,infection suppressed Cl secretion induced by CFTR activation in T-
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Fig. 4. The stimulus of CFTR activator-dependent 125I efﬂux was suppressed by C. jejuni infection in T-84 cells. T-84 cells were infected with C. jejuni for 12 h and were pre-loaded
with 125I. The 125I efﬂux in T-84 cells infected with C. jejuniwas measured at 2 min intervals for a 10 min period. 50 mM CPT-cAMP (a), 10 mM PGE2 (b) or 200 mM ATP (c) was added
0 min after starting the efﬂux measurements. Results are shown as the mean ± SD calculated from the results of 3 independent experiments.
S. Negoro et al. / J Infect Chemother xxx (2014) 1e76leading to mucus stasis. In CF patient lungs, mucus stasis leads to
chronic bacterial infections with bacteria such as Pseudomonas
aeruginosai [8]. Moreover, chronic infection in CF lung has been
considered to be caused bymucus pathology in the airway [27], and
it is suggested that destruction of mucus homeostasis by attenua-
tion of CFTR activity might also promote bacterial preservation in
the intestinal tract.
In the human intestine, MUC2 is the main secreted mucin
constituting the mucus layer. MUC1, MUC3, MUC4, MUC12, MUC13,
and MUC17 are the cell surface mucins. During infection, enteric
pathogens are known to stimulate mucus secretion. Similarly,
expression of MUC1 is upregulated in human colonic biopsies
following C. jejuni infection [28]. Muc1/ mice have a higher rate
of gastroenteritis in a mouse C. jejuni infection model [4]. These
data suggest that mucus plays a critical role in preventing C. jejuni
infection. Mucins are also known as the major chemoattractants for
C. jejuni [29], and modulation of mucin expression can inﬂuence
colonization and pathogenicity of C. jejuni [30]. Mucus is clearly
important for bacterial defense and regulation of bacterial coloni-
zation in the intestinal tract. We hypothesized that suppression of
CFTR-mediated water movement and mucus dehydration induced
by C. jejuni infection may contribute to not only defense but also
regulation of bacterial colonization in the intestinal tract.
To conclude, our results show that C. jejuni infection suppresses
forskolin-activated Cl secretion. This reaction is predicted to play a
key role in C. jejuni survival in the intestinal tract. Further investi-
gation of the relationship between C. jejuni infection and CFTR
would lead to a better understanding of C. jejuni survival.
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